Depression News

Jack Bowlby, a keen horserider from Kingston Lisle, near Wantage, was found dead in his room at Cheltenham College on October 12 last year, aged 16. He had taken the prescription drug Roaccutane for seven months, despite complaining to a nurse that he started experiencing "very dark thoughts", including suicide.

Taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone.

The Greater Rochester Health Foundation has recognized the work of Thomas L. Campbell, M.D. , the University of Rochester Medical Center's Highland Family Medicine practice and the Anthony L. Jordan Health Center through a Robert Oppenheimer Impact Award.

This is due to changes in a part of children's brains called the amygdala, which is responsible for controlling emotion and stress and is linked to anxiety disorders.

I was recently intrigued by the claims made - and that went completely unchallenged - by Vikram Patel, a psychiatrist who was interviewed by Wired Science's Greg Miller.

Boston, MA - Heart disease triples a person's risk of depression. At the same time, people who have from depression are at greatly increased risk of heart disease.

There are more than 19 million adults in the United States living with depression and many more people could be suffering but are unaware that what they are feeling is depression, according to the National Institute of Mental Health.

An Eli Lilly and Co. compound in testing to treat depression has faltered in late-stage patient trials.

Eli Lilly and Co. corporate headquarters at Delaware and McCarty streets in Downtown Indianapolis.

Eli Lilly & Co. will end development of the depression medicine edivoxetine as an add-on therapy after the drug failed to meet goals in three studies.

Unfortunately, misconceptions can be stumbling blocks to taking the action needed to overcome depression, which may prolong the illness and worsen its effects over time.

Eli Lilly & Co. will end development of the depression medicine edivoxetine as an add-on therapy after the drug failed to meet goals in three studies.

According to an announcement from Eli Lilly, three randomized placebo-controlled phase III studies of their investigational depression drug edivoxetine did not meet the primary objective of superior efficacy compared with placebo after 8 weeks of treatment in patients with major depressive disorder .

An Eli Lilly and Co. compound in testing to treat depression has faltered in late-stage patient trials.

Eli Lilly and Co. corporate headquarters at Delaware and McCarty streets in Downtown Indianapolis.

Eli Lilly and Co said on Thursday it would not seek approval for edivoxetine, its experimental drug to treat major depression, after it failed to meet its primary goal in three late-stage trials.

Here are some facts about belief in G-d and prayer that recent studies have shown.

Hey, check out all the research scientist jobs . Post your resume today!

In East Asian cultures, an adult son's role in the family is crucial to the wellbeing and financial stability of his parents, the researchers suggest.

University of York researchers and their clinical NHS colleagues are expanding a project to investigate the health and wellbeing of newborn babies and their parents to include a study of depression during pregnancy and early motherhood.